You are here:

News

Published on

Updated:

date:

Dual Breakthrough Therapy Designation in China and US for bexicaserin for the treatment of seizures in severe rare epilepsies

An investigational drug, bexicaserin has been granted Breakthrough Therapy Designation (BTD) by China’s Center for Drug Evaluation. The medicine has also been granted BTD by the U.S. Food and Drug Administration (FDA) for the treatment of seizures associated with severe, childhood-onset rare epilepsies.

 

date:

What we want from NhWes

Thank you to everyone who wrote to their Labour MP asking them to come and see us at our stand at the Labour Party Conference.  We were inundated with MPs wanting to find out more about epilepsy and support our campaigns as a result of your invitations. This will really help to amplify the voices of people with epilepsy in parliament. 

LET'S STAY IN TOUCH...

We send monthly e-newsletters to keep you informed with tips for managing epilepsy, the latest news, inspirational stories, fundraising opportunities and further information from Epilepsy Society.

Read our privacy policy

It is always your choice as to whether you want to receive information from us. You may opt-out of our marketing communications by clicking the ‘unsubscribe’ link at the end of our marketing emails or through our unsubscribe number 0300 102 0025.